CIK 0000874015
- Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 330336973
- Phone
- +1 760-931-9200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −1,995 | $49.67 | $99K | 48,627 |
| 2024-02-02 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale | −2,106 | $49.59 | $104K | 47,659 |
| 2024-02-02 | Swayze Eric EVP Research | Sale | −1,940 | $49.56 | $96K | 34,291 |
| 2024-02-02 | Monia Brett P Chief Executive Officer | Sale | −23,907 | $49.37 | $1.2M | 173,732 |
| 2024-02-02 | Cadoret-Manier Onaiza EVP,Chf GL Pdt Str & Oper Ofc | Sale | −2,162 | $49.60 | $107K | 35,788 |
| 2024-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,885 | $49.52 | $93K | 79,047 |
| 2024-02-02 | Monia Brett P Chief Executive Officer | Sale | −23,907 | $49.37 | $1.2M | 173,732 |
| 2024-02-02 | Swayze Eric EVP Research | Sale 10b5-1 | −1,907 | $49.56 | $95K | 34,324 |
| 2024-02-02 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale | −2,071 | $49.59 | $103K | 49,812 |
| 2024-02-02 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale | −1,961 | $49.67 | $97K | 48,661 |
| 2024-02-02 | Monia Brett P Chief Executive Officer | Sale | −23,501 | $49.37 | $1.2M | 174,138 |
| 2024-02-02 | HOUGEN ELIZABETH L EVP, Finance & CFO | Sale | −2,125 | $49.54 | $105K | 92,905 |
| 2024-02-02 | Geary Richard S EVP, Chief Development Officer | Sale | −1,961 | $50.04 | $98K | 87,334 |
| 2024-02-02 | Cadoret-Manier Onaiza EVP, Chf GL Pdt Str & Oper Ofc | Sale | −2,125 | $49.60 | $105K | 35,825 |
| 2024-02-02 | BENNETT C FRANK EVP, Chief Scientific Officer | Sale | −1,853 | $49.52 | $92K | 79,079 |
| 2024-02-01 | Swayze Eric EVP Research | Grant or award 10b5-1 | +3,715 | 36,231 | ||
| 2024-02-01 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Grant or award | +4,033 | 51,883 | ||
| 2024-02-01 | O'NEIL PATRICK R. EVP CLO & General Counsel | Grant or award | +3,820 | 50,622 | ||
| 2024-02-01 | Monia Brett P Chief Executive Officer | Grant or award | +25,372 | 177,223 | ||
| 2024-02-01 | Monia Brett P Chief Executive Officer | Grant or award | +20,416 | 197,639 |
Page 40 of 44 · 873 trades